This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Donghui Wu, PhD
Director, CRO Services at WuXi Biologics
Speaker

Profile

Dr. Donghui Wu, has 20+ years of extensive experience in antibody discovery, engineering, and macromolecular structural biology. He solved 10+ protein or protein complex crystal structures including several antibody-antigen complex structures and published 10+ peer reviewed articles as first author or correspondence author. Before joining WuXi Biologics in 2020, he worked as a Co-PI (Co-Principal Investigator) and Research Associate Professor in the Laboratory of Antibody Engineering, Shanghai Tech University. Dr. Donghui Wu received his Ph.D. degree in medical macromolecule structural biology from National University of Singapore in 2010.